Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte: Involvement of κ-opioid receptor

Circulation Research

Volumn 84, Issue 12, 1999, Pages 1388-1395

  Wu, S ^b   Li, H Y ^b   Wong, T M ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b NONE

Author keywords

Ca2+; Contractility; Myocyte; Protein kinase; Receptor

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; BINALTORPHIMINE; DEOXYGLUCOSE; KAPPA OPIATE RECEPTOR; NALTRINDOLE; SODIUM CYANIDE; TRYPAN BLUE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE SEVERITY; HEART CONTRACTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; METABOLIC INHIBITION; NONHUMAN; PRIORITY JOURNAL; RAT; TIME;

EID: 0033603567     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.84.12.1388     Document Type: Article

References (50)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia, a delay of lethal cell injury in ischemic myocardium. Circulation. 1986; 74:1124-1136.
2. Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation. 1993;88: 1264-1272.
3. Zhou X, Zhai X, Ashraf M. Direct evidence that initial oxidative stress triggered by preconditioning contributes to second window of protection by endogenous antioxidant enzyme in myocytes. Circulation. 1996;93: 1177-1184.
4. Armstrong SC, Downey JM, Ganote CE. Preconditioning of isolated rabbit cardiomyocytes: induction by metabolic stress and blockade by the adenosine antagonist SPT and calphostin C, a protein kinase C inhibitor. Cardiovasc Res. 1994;28:72-77.
5. Rubin Y, Uretzky G, Sharony R, Less H, Binah O. Preconditioning of cardiac myocytes with calcium. J Mol Cell Cardiol. 1998;30:A88:343. Abstract.
6. Schultz JE, Rose E, Yao Z, Gross GJ. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol. 1995; 268(pt 2):H2157-H2161.
7. Chien GL, Winkle DMV. Naloxone blockade of myocardial ischemic preconditioning is stereoselective. J Mol Cell Cardiol. 1996;28: 1895-1900.
8. Meerson FZ, Ustinova EE, Orlova EH. Prevention and elimination of heart arrhythmias by adaptation to intermittent high altitude hypoxia. Clin Cardiol. 1987;10:783-789.
9. Chien S, Oeltgen PR, Diana JN, Salley RK. Extension of tissue survival time in multiorgan block preparation with a δ-opioid DADLE. J Thorac Cardiovasc Surg. 1994;107:964-967.
10. Schultz JJ, Hsu AK, Gross GJ. Ischemic preconditioning and morphine-induced cardioprotection involve the δ-opioid receptor in the intact rat heart. J Mol Cell Cardiol. 1997;29:2187-2195.
11. Xia Q, Zhang WM, Shen YL, Wong TM. Decreased affinity of κ-receptor binding during reperfusion following ischemic preconditioning in the rat heart. Life Sci. 1996;58:1307-1317.
12. 3H]-U69593 binding sites in the rat heart by receptor binding studies. J Mol Cell Cardiol. 1991;23:1297-1302.
13. Ventura C, Bastagli L, Bernardi P, Cardarera CM, Guarnieri C. Opioid receptors in rat cardiac sarcolemma: effect of phenylephrine and isoproterenol. Biochim Biophys Acta. 1989;987:69-74.
14. Nayeem MA, Hess ML, Qian YZ, Loesser KE, Kukreja RC. Delayed preconditioning of cultured adult rat cardiac myocytes: role of 70- and 90-kDa heat stress proteins. Am J Physiol. 1997;273:H861-H868.
15. Baxer GF, Goma FM, Yellon DM. Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardium. Br J Pharmacol. 1995;115:222-224.
16. 2+ in cardiac myocytes. Am J Physiol. 1991;261: H1671-H1674.
17. Bian JS, Wang HX, Zhang WM, Wong TM. Effects of κ-opioid receptor stimulation in the heart and the involvement of protein kinase C. Br J Pharmacol. 1998;124:600-606.
18. Dong H, Sheng JZ, Lee CM, Wong TM. Calcium antagonistic and antiarrhythmic action of CPU23, a substituted tetrahydroisoquinoline. Br J Pharmacol. 1993;109:113-119.
19. 2+ elevation evoked by κ-opioid in rat myocytes. Eur J Pharmacol. 1996;307:323-329.
20. Hiebert L, Ping T. Protective effect of dextran sulfate and heparin on adult rat cardiomyocytes damaged by free radicals. J Mol Cell Cardiol. 1997;29:229-235.
21. Yu XC, Li HY, Wang HX, Wong TM. U50,488H inhibits effects of norepinephrine in rat cardiomyocytes: cross talk between κ-opioid and β-adrenergic receptors. J Mol Cell Cardiol. 1998;30:405-413.
22. 3H]-U69,593 binding and the cardiac effects of U50,488H by calcium channel blockers in the rat heart. Br J Pharmacol. 1997;120:827-832.
23. 2+ transient. Circ Res. 1991;69: 1369-1379.
24. Devine DP, Leone P, Wise RA. Mesolimbic dopamine neurotransmission is increased by administration of μ-opioid receptor antagonists. Eur J Pharmacol. 1993;243:55-64.
25. Portoghese PS, Sultana M, Takemori AE. Naltrindole, a highly selective and potent non-peptide δ-opioid receptor antagonist. Eur J Pharmacol. 1988;146:185-186.
26. Blake AD, Bot G, Li S, Freeman JC, Reisine T. Differential agonists regulation of the human κ-opioid receptor. J Neurochem. 1997;68: 1846-1852.
27. Portoghese PS, Lin CE, Farouz-Gram GF, Takemori AE. Structure-activity relationship of N17′-substituted norbinaltorphimine congeners: role of the N17′ basic group in the interaction with a putative address subsite on the κ-opioid receptor. J Med Chem. 1994;37:1495-1500.
28. Lahti RA, Vonvoigtlander PF, Barsuhn C. Properties of a selective kappa agonist, U-50,488H. Life Sci. 1982;31:2257-2260.
29. Vonvoigtlander PF, Lahti RA, Ludens JH. U-50,488H: a selective and structurally novel non-μ (κ) opioid agonist. J Pharmacol Exp Ther. 1983;224:7-12.
30. ATP channel. Am J Physiol. 1997; 273:H847-H853.
31. 2+ pathway in the cardiac κ-opioid receptor. Am J Physiol. 1998;274: C82-C87.
32. Kasper E, Ventura C, Ziman BD, Lakatta EG, Weisman H, Capogrossi MC. Effect of U50,488H on the contractile response of cardiomyopathic hamster ventricular myocytes. Life Sci. 1992;50:2029-2035.
33. i in myocytes. Am J Cardiol. 1997;272:C560-C564.
34. Schoffelmeer AN, Hogenboom F, Mulder AH. Kappa 1- and kappa 2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum. Br J Pharmacol. 1997;122: 520-524.
35. Giuliani S, Maggi CA. Prejunctional modulation by nociceptin of nerve-mediated inotropic responses in guinea pig left atrium. Eur J Pharmacol. 1997;332:231-236.
36. Connor M, Ingram SL, Christie MJ. Cortistatin increase of a potassium conductance in rat locus coeruleus in vitro. Br J Pharmacol. 1997;122: 1567-1572.
37. Lupica CR. δ- and μ-enkephalins inhibit spontaneous GABA-mediated IPSCs via a cyclic AMP-independent mechanism in the rat hippocampus. J Neurosci. 1995;15:737-749.
38. + exchanger: evidence for a receptor-mediated mechanism involving protein kinase C. Circ Res. 1996;79:705-715.
39. Jovanovic A, Alekseev AE, Lopez JR, Shen WK, Terzic A. Adenosine prevents hyperkalemia-induced calcium loading in cardiac cells: relevance for cardioplegia. Ann Thorac Surg. 1997;63:153-161.
40. Nishida M, Borzak S, Kraemer B, Navas JP, Kelly RA, Smith TW, Marsh JD. Role of cation gradients in hypercontracture of myocytes during simulated ischemia and reperfusion. Am J Physiol. 1993;264: H1896-H1906.
41. Eisner DA, Nichols CG, O'Neill SC, Smith GL, Valdeolmillos M. The effects of metabolic inhibition on intracellular calcium and pH in isolated rat ventricular cells. J Physiol. 1989;411:393-418.
42. Wong TM, Lee AYS, Tai KK. Effects of drugs interacting with opioid receptors during normal perfusion or ischemia and reperfusion in the isolated rat heart: an attempt to identify cardiac opioid receptor subtype(s) involved in arrhythmogenesis. J Mol Cell Cardiol. 1990;22:1167-1175.
43. 1- but not μ- or κ-opioid receptors. Circulation. 1998;97:1282-1289.
44. Opie LH. The mechanism of myocyte death in ischemia. Eur Heart J. 1993;14(suppl G):31-33.
45. Opie LH. Cardiac metabolism: emergence, decline and resurgence; part I. Cardiovasc Res. 1992; 26:721-733.
46. 2+ as a mediator of ischemic preconditioning. Circ Res. 1997;80:790-799.
47. Tai KK, Bian CF, Wong TM. κ-Opioid receptor stimulation increases intracellular free calcium in isolated rat ventricular myocytes. Life Sci. 1992;51:909-913.
48. Ventura C, Guarnieri C, Vaona I, Campana G, Pintus G, Spampinato S. Dynorphin gene expression and release in the myocardial cell. J Biol Chem. 1994;269:5384-5396.
49. 2+ release from a intracellular pool in myocytes and neurons. Circ Res. 1992;70:66-81.
50. + current by protein kinase C and adenosine. Circ Res. 1996;78:443-454.